Toxoplasma gondii antigens recognized by IgG antibodies differ between mice with and without active proliferation of tachyzoites in the brain during the chronic stage of infection

Infection and Immunity

Volumn 80, Issue 10, 2012, Pages 3611-3620

  Hester, James ^a,d   Mullins, Jeremi ^a   Sa, Qila ^a   Payne, Laura ^b   Mercier, Corinne ^c   Cesbron Delauw, Marie France ^c   Suzukia, Yasuhiro ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b CENTER FOR MOLECULAR MEDICINE AND INFECTIOUS DISEASES   (United States)

^c CNRS   (France)

^d ParaTechs Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRA4 PROTEIN; GRA7 PROTEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN G; MAG1 PROTEIN; MIC2 PROTEIN; MYOSIN HEAVY CHAIN; PARASITE ANTIGEN; PROTOZOAL PROTEIN; ROP1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; IMMUNOBLOTTING; IMMUNOCOMPETENCE; MICROBIAL GROWTH; MOUSE; NONHUMAN; PRIORITY JOURNAL; TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMOSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ANTIPROTOZOAL AGENTS; BRAIN; CHRONIC DISEASE; FEMALE; GENE EXPRESSION REGULATION; IMMUNOGLOBULIN G; MICE; MICE, INBRED CBA; RNA, MESSENGER; SULFADIAZINE; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

EID: 84867612888     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00604-12     Document Type: Article

References (40)

1. Achbarou A, et al. 1991. Differential targeting of dense granule proteins in the parasitophorous vacuole of Toxoplasma gondii. Parasitology 103(Part 3):321-329.
2. Ajzenberg D, et al. 2002. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J. Infect. Dis. 186:684-689.
3. Aubert D, et al.2000. Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulinMin human sera by enzyme immunoassay. J. Clin. Microbiol. 38:1144-1150.
4. Blumenschein TM, et al. 2007. Atomic resolution insight into host cell recognition by Toxoplasma gondii. EMBO J. 26:2808-2820
5. Boyer K, Marcinak J, McLeod R. 2007. Toxoplasma gondii (toxoplasmosis), p 1267-1288. , Principles and practice of pediatric infectious diseases, In Long S, Pickering LK, Prober CG (ed) 3rd ed. Churchill Livingstone, New York, NY.
6. Brooks RG, McCabe RE, Remington JS. 1987. Role of serology in the diagnosis of toxoplasmic lymphadenopathy. Rev. Infect. Dis. 9:1055-1062.
7. Brown CR, et al. 1995. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology 85:419-428.
8. Cerede O, et al. 2005. Synergistic role of micronemal proteins in Toxoplasma gondii virulence. J. Exp. Med. 201:453-463.
9. Darde ML, Bouteille B, Pestre-Alexandre M. 1992. Isoenzyme analysis of 35 Toxoplasma gondii isolates and the biological and epidemiological implications. J. Parasitol. 78:786-794.
10. Denkers EY, Gazzinelli RT. 1998. Regulation and function of T-cellmediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 11:569-588.
11. Derouin F, Rabian-Herzog C, Sulahian A. 1989. Longitudinal study of the specific humoral and cellular response to Toxoplasma gondii in a patient with acquired toxoplasmosis. J. Clin. Lab. Immunol. 30:97-102.
12. Di Cristina M, et al. 2004. The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection. Microbes Infect. 6:164-171.
13. Echeverria PC, et al. 2005. Toxoplasma gondii Hsp90 is a potential drug target whose expression and subcellular localization are developmentally regulated. J. Mol. Biol. 350:723-734.
14. Golkar M, et al. 2007. The dense granule protein GRA2, a new marker for the serodiagnosis of acute Toxoplasma infection: comparison of sera collected in both France and Iran from pregnant women. Diagn. Microbiol. Infect. Dis. 58:419-426.
15. Golkar M, et al. 2007. Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice. Vaccine 25:4301-4311.
16. Grigg ME, Bonnefoy S, Hehl AB, Suzuki Y, Boothroyd JC. 2001. Success and virulence in Toxoplasma as the result of sexual recombination between two distinct ancestries. Science 294:161-165.
17. Holec-Gasior L, Kur J, Hiszczynska-Sawicka E. 2009. GRA2 and ROP1 recombinant antigens as potential markers for detection of Toxoplasma gondii-specific immunoglobulin G in humans with acute toxoplasmosis. Clin. Vaccine Immunol. 16:510-514.
18. Howe DK, Sibley LD. 1995. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J. Infect. Dis. 172:1561-1566.
19. Huskinson J, et al. 1989. Toxoplasma antigens recognized by immunoglobulin G subclasses during acute and chronic infection. J. Clin. Microbiol. 27:2031-2038.
20. Kang H, Suzuki Y. 2001. Requirement of non-T cells that produce gamma interferon for prevention of reactivation of Toxoplasma gondii infection in the brain. Infect. Immun. 69:2920-2927.
21. Kasper LH. 1989. Identification of stage-specific antigens of Toxoplasma gondii. Infect. Immun. 57:668-672
22. Leweke FM, et al. 2004. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 254:4-8.
23. Luo Q, et al. 2011. Analysis of the glycoproteome of Toxoplasma gondii using lectin affinity chromatography and tandem mass spectrometry. Microbes Infect. 13:1199-1210.
24. McCabe RE, Remington JS. 1990. Toxoplasma gondii, p 2090. , Principles and practice of infectious diseases, In Mandell GL, Douglas RG, Bennett JE (ed) 3rd ed. Churchill Livingstone Inc., New York, NY.
25. Mercier C, Adjogble KD, Daubener W, Delauw MF. 2005. Dense granules: are they key organelles to help understand the parasitophorous vacuole of all apicomplexa parasites? Int. J. Parasitol. 35:829-849.
26. Mercier C, Travier L, Bittame A, Gendrin C, Cesbron-Delauw MF. 2010. The dense granule proteins of Toxoplasma gondii, p 1-31. , Parasitology research trends In De Bruyn O, Peeters S (ed). Nova Science Publishers Inc., Hauppauge, NY.
27. Parmley SF, et al. 1994. Molecular characterization of a 65-kilodalton Toxoplasma gondii antigen expressed abundantly in the matrix of tissue cysts. Mol. Biochem. Parasitol. 66:283-296.
28. Pfrepper KI, et al. 2005. Seroreactivity to and avidity for recombinant antigens in toxoplasmosis. Clin. Diagn. Lab. Immunol. 12:977-982.
29. Pusch L, Romeike B, Deckert M, Mawrin C. 2009. Persistent toxoplasma bradyzoite cysts in the brain: incidental finding in an immunocompetent patient without evidence of a toxoplasmosis. Clin. Neuropathol. 28:210-212.
30. Santos JM, Soldati-Favre D. 2011. Invasion factors are coupled to key signalling events leading to the establishment of infection in apicomplexan parasites. Cell. Microbiol. 13:787-796.
31. Sawmynaden K, et al. 2008. Structural insights into microneme protein assembly reveal a new mode of EGF domain recognition. EMBO Rep. 9:1149-1155.
32. Silva NM, et al. 1998. Expression of Toxoplasma gondii-specific heat shock protein 70 during in vivo conversion of bradyzoites to tachyzoites. Infect. Immun. 66:3959-3963.
33. Singh J, et al. 2010. Toxoplasma IgG and IgA, but not IgM, antibody titers increase in sera of immunocompetent mice in association with proliferation of tachyzoites in the brain during the chronic stage of infection. Microbes Infect. 12:1252-1257.
34. Stommel EW, et al. 2001. Cryptogenic epilepsy: an infectious etiology? Epilepsia 42:436-438.
35. Suzuki Y, Joh K, Orellana MA, Conley FK, Remington JS. 1991. A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice. Immunology 74:732-739.
36. Suzuki Y, Orellana MA, Wong SY, Conley FK, Remington JS. 1993. Susceptibility to chronic infection with Toxoplasma gondii does not correlate with susceptibility to acute infection in mice. Infect. Immun. 61: 2284-2288.
37. Suzuki Y, Thulliez P, Desmonts G, Remington JS. 1988. Antigen(s) responsible for immunoglobulinGresponses specific for the acute stage of Toxoplasma infection in humans. J. Clin. Microbiol. 26:901-905.
38. Suzuki Y, et al. 2010. Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+T cells. Am. J. Pathol. 176:1607-1613.
39. Torrey EF, Yolken RH. 2003. Toxoplasma gondii and schizophrenia. Emerg. Infect. Dis. 9:1375-1380.
40. Wang X, Michie SA, Xu B, Suzuki Y. 2007. Importance of IFN-gammamediated expression of endothelial VCAM-1 on recruitment of CD8+ T cells into the brain during chronic infection with Toxoplasma gondii. J. Interferon Cytokine Res. 27:329-338.